Article Text
Statistics from Altmetric.com
Objective
To evaluate the effectiveness and safety of the nicotine inhaler as an adjunct to group support in smoking cessation.
Design
1 year, randomised, double blind, placebo controlled trial.
Setting
Smoking cessation clinic at a university hospital in Göteborg, Sweden.
Patients
247 persons who were ≥20 years of age (mean age 48 y, 64% women), smoked ≥10 cigarettes per day, smoked for ≥3 years, and had made a previous serious attempt to quit smoking using nicotine chewing gum. Exclusion criteria included severe cardiovascular disease; pregnancy; breast feeding; use of psychotropic drugs, smokeless tobacco, or snuff; abuse of alcohol or any other drugs during the past 12 months; nicotine replacement therapy during the past 12 months; and acute medical illness. Follow up was 94%.
Intervention
Participants attended support sessions …
Footnotes
Source of funding: Pharmacia & Upjohn, Helsingborg, Sweden.
For article reprint: Dr A Hjalmarson, Smoking Cessation Clinic, Sahlgrenska University Hospital, 413 45 Goteborg, Sweden. Fax +46 31 416639.